New drugs to solve new problems or old problems better would continue receiving protections, and the incentives would remain in place. How do you think about t

New drugs to solve new problems or old problems better would continue receiving protections, and the incentives would remain in place. How do you think about the nationalisation of generics of existing drugs being detrimental to new drugs' development?